Figure Legends
Figure 1. COVID-positive pediatric oncology patients who
develop severe cardiorespiratory symptoms have significantly increased
cumulative anthracycline exposure and decreased pre-COVID cardioechogram
shortening fractions compared to COVID-positive counterparts who did not
develop cardiorespiratory symptoms. Comparison of (A) age, (B) white
blood cell count, (C) absolute lymphocyte count, (D) absolute neutrophil
count, (E) platelets, (F) cumulative anthracycline exposure, and (G)
pre-COVID cardiac echocardiogram shortening fraction in COVID-positive
pediatric oncology patients who developed severe and mild clinical
symptoms. Severe cardiorespiratory symptoms as defined by evidence of
heart failure and/or intubation secondary to respiratory failure. Bars
= Mean+ SEM. Points represent values from individual patients.
Shapiro-Wilk normality test was performed on each data set. The
appropriate parametric (student t-test) or non-parametric (Mann-Whitney)
test was then used. ns, non-significant. *, p<0.05. **,
p<0.01. ***, p<0.001.